Fluphenazine-d8 Dihydrochloride
Modify Date: 2024-09-15 15:41:38
Fluphenazine-d8 Dihydrochloride structure
|
Common Name | Fluphenazine-d8 Dihydrochloride | ||
|---|---|---|---|---|
| CAS Number | 1323633-98-2 | Molecular Weight | 445.570843824 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H18D8F3N3OS | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Fluphenazine-d8 DihydrochlorideFluphenazine-d8 is the deuterium labeled Fluphenazine. Fluphenazine is a potent, orally active phenothiazine-based dopamine receptor antagonist. Fluphenazine blocks neuronal voltage-gated sodium channels. Fluphenazine acts primarily through antagonism of postsynaptic dopamine-2 receptors in mesolimbic, nigrostriatal, and tuberoinfundibular neural pathways. Fluphenazine can antagonize Methylphenidate-induced stereotyped gnawing and inhibit climbing behaviour in mice. Fluphenazine can be used for researching psychosis and painful peripheral neuropathy associated with diabetes and has potential to inhibit SARS-CoV-2[1][2][3][4][5][6]. |
| Name | 2-[2,2,3,3,5,5,6,6-octadeuterio-4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol |
|---|
| Description | Fluphenazine-d8 is the deuterium labeled Fluphenazine. Fluphenazine is a potent, orally active phenothiazine-based dopamine receptor antagonist. Fluphenazine blocks neuronal voltage-gated sodium channels. Fluphenazine acts primarily through antagonism of postsynaptic dopamine-2 receptors in mesolimbic, nigrostriatal, and tuberoinfundibular neural pathways. Fluphenazine can antagonize Methylphenidate-induced stereotyped gnawing and inhibit climbing behaviour in mice. Fluphenazine can be used for researching psychosis and painful peripheral neuropathy associated with diabetes and has potential to inhibit SARS-CoV-2[1][2][3][4][5][6]. |
|---|---|
| Related Catalog |
| Molecular Formula | C22H18D8F3N3OS |
|---|---|
| Molecular Weight | 445.570843824 |